Consequently, loss of NID-2 has been implicated in various malignant neoplasms, such as gastric and lung carcinomas (Guerrero-Preston et al., 2011; Chai et al., 2018; Srisuttee et al., 2020; Chettiankandy et al., 2022). The gene discussed is NID2; the disease is cancer.